TrialEuropean heart journal2012

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial.

Thomas F Lüscher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.